JPRN-jRCT2011210041进行中（未招募）3 期
Phase III Clinical Study of ME3208 in Patients with Steroid-Dependent/Resistant Chronic Graft Versus Host Disease
Kijima Koji0 个研究点目标入组 20 人开始时间: 2021年10月18日最近更新:
适应症
试验速览
- 阶段
- 3 期
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 20
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- >= 12age old 至 ot applicable（—）
- 性别
- All
入选标准
- •1) Patients who are able to provide written informed consent
- •2) Patients who received allogeneic hematopoietic cell transplantation (aHCT)
- •3) Patients diagnosed with moderate to severe chronic GVHD
- •4) Patients defined as steroid-dependent/refractory chronic GVHD at any time point after aHCT
- •5) Patients with the performance scale of 60 or more at baseline
排除标准
- •1) Patients with active acute GVHD
- •2) Patients with post-transplant lymphoproliferative disease
- •3) Patients with a severe past history or complications (malabsorption syndrome, poorly controlled psychiatric disease, coronary artery disease, etc.) that may affect the evaluation of this study as judged by the principal investigator or subinvestigator
- •4) Patients who cannot maintain medication adherence as judged by the principal investigator or subinvestigator
- •5) Patients for whom the principal investigator or subinvestigator judged that the implementation of this study is inappropriate
研究者
相似试验
未知
3 期
Open Phase III Study of ME2080 in Patients with Dravet SyndromeDravet SyndromeJPRN-jRCT2080221082Meiji Seika Pharma Co., Ltd. (formerly MEIJI SEIKA KAISHA Co., LTD.)25
招募中
1 期
Study of LY3537982 in Cancer Patients with a Specific Genetic Mutation (KRAS G12C)SCLCCRCEndometrial NeoplasmsOvarian NeoplasmsPancreatic NeoplasmsBiliary Tract NeoplasmsFrontline, 1L, First LineJPRN-jRCT2031210265Masaki Takeshi80
未知
2 期
Phase II Study of ME3738 prolonged administration in Chronic Hepatitis C patients.Chronic Hepatitis CJPRN-jRCT2080221188MEIJI SEIKA KAISHA, LTD.
进行中（未招募）
不适用
A Phase II study of MGCD0103 (MG-0103) in patients with acute myelogenous leukemia/high risk MDS who are elderly and have previously untreated disease or who are adult and have relapsed/refractory diseaseAcute myelogenous leukemia or high risk myelodysplastic syndromes in patients who are elderly and have previously untreated disease or who are adult and have relapsed or refractory disease.MedDRA version: 8.1Level: LLTClassification code 10000886Term: Acute myeloid leukemiaEUCTR2006-005872-42-GBPharmion GmbH82
未知
2 期
Phase II clinical study of HP-3150 in patients with low back pain.ow back painJPRN-jRCT2080222960Hisamitsu Pharmaceutical Co., Inc